Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and activation levels of drug targets in breast tumors. This innovative ...

Ignite Proteomics announces the publication of a significant study in the British Journal of Cancer titled “Functional activation of the ...

"ERBB2 and PTEN are a part of different signaling pathways, but we believe they have a correlation in endometrial cancer," ...

The research indicated that deguelin's ability to enhance PTEN and KLF4 expression could ... forming new tumors. Signaling Pathways: Complex networks of molecules in a cell that work together ...